Insider · CIK 0001566240
Joshua R. Disbrow
Files at ZYXI (ZYNEX INC), AYTU (AYTU BIOPHARMA, INC). First filing Mar 3, 2025, latest Jun 10, 2025.
In brief
Joshua R. Disbrow files SEC Form 4 as CEO and director at AYTU (AYTU BIOPHARMA, INC), and also at ZYXI (ZYNEX INC). Since Mar 3, 2025, Joshua R. Disbrow has reported 2 open-market buys worth $119k and 0 open-market sells worth $0, the latest filed on Jun 10, 2025.
A track record needs three past buys with six months of prices behind them; Joshua R. Disbrow has 0, so none is measured yet.
The newest scored trade: bought $100k of AYTU on Jun 9, 2025, filed Jun 10, 2025, scored 57 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AYTU: AYTU BIOPHARMA, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | AYTU BIOPHARMA, INC | $100k 66,666 shares | +77% | +111% from low-26% from high | |
| 31Weak | AYTUbuy AYTU BIOPHARMA, INC | $20k 15,000 shares | +21% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 237,203 | Jul 30, 2026 |
| Mar 26, 2026 | ZYXI ZYNEX INC | DDisposition to issuer Common Stock (Restricted Stock Award) | -12,499 | $0.00 | $0 | 0 | Mar 27, 2026 |
| Mar 26, 2026 | ZYXI ZYNEX INC | DDisposition to issuer Common Stock | -89,501 | $0.00 | $0 | 0 | Mar 27, 2026 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +31,446 | $0.00 | $0 | 184,703 | Oct 7, 2025 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +22,500 | $0.00 | $0 | 207,203 | Oct 7, 2025 |
| Jun 9, 2025 | AYTU AYTU BIOPHARMA, INC | POpen-market purchase Common Stock | +66,666 | $1.50 | $100k | 153,257 | Jun 10, 2025 |
| May 15, 2025 | ZYXI ZYNEX INC | AGrant or award Common Stock (Restricted Stock Award) | +10,000 | $0.00 | $0 | 22,500 | May 16, 2025 |
| Feb 28, 2025 | AYTU AYTU BIOPHARMA, INC | POpen-market purchase Common Stock | +15,000 | $1.30 | $20k | 86,591 | Mar 3, 2025 |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | AGrant or award Employee Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Nov 8, 2024 |
Questions about Joshua R. Disbrow
Answered from the filings on this page, as of the latest one.
Is Joshua R. Disbrow buying or selling?
Not in the last 12 months. Joshua R. Disbrow's latest open-market trade on SEC Form 4 was bought $100k of AYTU on Jun 9, 2025.
How did Joshua R. Disbrow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joshua R. Disbrow has 0.
Where does Joshua R. Disbrow file Form 4?
Joshua R. Disbrow has filed Form 4 at AYTU (AYTU BIOPHARMA, INC) as Chief Executive Officer; ZYXI (ZYNEX INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.